Transgene-Free Disease-Specific Induced Pluripotent Stem Cells from Patients with Type 1 and Type 2 Diabetes

The induced pluripotent stem cell (iPSC) technology enables derivation of patient-specific pluripotent stem cells from adult somatic cells without using an embryonic cell source. Redifferentiation of iPSCs from diabetic patients into pancreatic islets will allow patient-specific disease modeling and...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kudva, Yogish C., Ohmine, Seiga, Greder, Lucas V., Dutton, James R., Armstrong, Adam, De Lamo, Josep Genebriera, Khan, Yulia Krotova, Thatava, Tayaramma, Hasegawa, Mamoru, Fusaki, Noemi, Slack, Jonathan M.W., Ikeda, Yasuhiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2012
Aiheet:
Embryonic Stem Cells/Induced Pluripotent Stem (iPS) Cells
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3652675/
https://ncbi.nlm.nih.gov/pubmed/23197849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2011-0044
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia